Digital Care's Burden on Patients

Overview

Información sobre este estudio

The purpose of this study is to evaluate the burdensome aspects of digital healthcare for a diverse range of chronic patients with varying levels of digital comfort.

The study will have three phases:

  • interviewing up to 40 patients to elicit content related to the burden of digital interventions for healthcare self-management (DRx) and understand how well the current TBQ capture it (Aim 1a);
  • patient-centered, iterative development (i.e., item generation), cognitive testing, and refinement of an adapted TBQ that addresses DRx (Aim 1b); and
  • field testing of DRx TBQ to test its validity (Aim 2).

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Age ≥ 18 years.
  • A clinician-diagnosed Type 1, Type 2, or gestational diabetes.
  • Receiving diabetes care by any clinician at the Division of Endocrinology.
  • Use any treatment to achieve glycemic control.
  • Users of any form of digital device or software for diabetes management.
  • Ability to read, speak, and understand English.
  • Access to telephone/videoconferencing technology for interviews or ability to meet study staff in person for an interview.
  • Ability and willingness to participate in all study related surveys and questionnaires.

Exclusion Criteria:

  • Patients for whom caregivers are the main users of digital tools in support of the patient’s care.
  • Participants who, in the opinion of the research staff, exhibit clinically significant cognitive or memory (e.g., the participant has trouble holding a conversation, or the participant exhibits signs of disorientation) or sensorial impairment that limits the participant’s ability to give informed consent.

Eligibility last updated 7/26/23. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Victor Montori, M.D.

Abierto para la inscripción

Contact information:

Misk Al Zahidy M.S.

(507) 255-0241

alzahidy.misk@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20553877

Mayo Clinic Footer